Professional Seasonal Analysis for Trading

Silexion Therapeutics Corp - Ordinary Shares (SLXN)

Seasonality Analysis

Stocks 6 Years Analyzed

Silexion Therapeutics Corp - Ordinary Shares Annual Seasonality Statistics

130.97%
Avg Annual Return
51.1%
Avg Monthly Win Rate
3/12
Positive Months
6
Years Analyzed

Silexion Therapeutics Corp - Ordinary Shares Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January -1.21%
40%
Weak
February -7.07%
40%
Weak
March -3.62%
80%
Weak
April -3.76%
33%
Very Weak
May 0.92%
60%
Moderate
June -2.17%
60%
Weak
July 6.59%
100%
Very Strong
August WORST -21.48%
40%
Weak
September -20.71%
60%
Weak
October -11.75%
40%
Weak
November BEST 208.45%
40%
Weak
December -13.20%
20%
Very Weak

Silexion Therapeutics Corp - Ordinary Shares 2026 vs Historical Pattern

Current Position
2.41
Historical Avg Position
46.57
Deviation
-44.16
Performance
Significantly Below Average

Silexion Therapeutics Corp - Ordinary Shares Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for SLXN with overlay patterns, custom date ranges, and more.

Create Free Account

Silexion Therapeutics Corp - Ordinary Shares Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Silexion Therapeutics Corp - Ordinary Shares Seasonal Historical Performance

Historical Performance

See historical average returns for SLXN across multiple timeframes.

Create Free Account

About Silexion Therapeutics Corp - Ordinary Shares (SLXN) Seasonality

Silexion Therapeutics Corp - Ordinary Shares (SLXN) has been analyzed using 6 years of historical data to identify seasonal patterns. Classified under Stocks, Silexion Therapeutics Corp - Ordinary Shares shows distinct seasonal tendencies based on historical data.

The strongest month for Silexion Therapeutics Corp - Ordinary Shares is historically November, with an average return of 208.45% and a win rate of 40%. Conversely, August tends to be the weakest month, averaging -21.48% return.

Looking at the full calendar year, Silexion Therapeutics Corp - Ordinary Shares has an average annual return of 130.97% with an overall monthly win rate of 51.1%. Out of 12 months, 3 typically show positive average returns.

The seasonal pattern for Silexion Therapeutics Corp - Ordinary Shares has a consistency score of 23.5 (Poor), based on 6 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Silexion Therapeutics Corp - Ordinary Shares Seasonality FAQ

What is the best month to buy Silexion Therapeutics Corp - Ordinary Shares (SLXN)?

Historically, November has been the best month for Silexion Therapeutics Corp - Ordinary Shares, with an average return of 208.45% and a win rate of 40%. However, past performance does not guarantee future results.

What is the worst month for Silexion Therapeutics Corp - Ordinary Shares (SLXN)?

Based on historical data, August has been the weakest month for Silexion Therapeutics Corp - Ordinary Shares, with an average return of -21.48%. This is a historical observation and does not guarantee future results.

How reliable is SLXN seasonality data?

The seasonality analysis for Silexion Therapeutics Corp - Ordinary Shares is based on 6 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Silexion Therapeutics Corp - Ordinary Shares seasonality in my trading?

Use Silexion Therapeutics Corp - Ordinary Shares (SLXN) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.